On the sense of taste in two Malagasy Primates (Microcebus murinus and Eulemur mongoz)

The relationship between phylogeny and taste is of growing interest. In this study we present recordings from the chorda tympani proper (CT) nerve of two lemuriforme primates, the lesser mouse lemur (Microcebus murinus) and the mongoose lemur (Eulemur mongoz), to an array of taste stimuli which included the sweeteners acesulfame-K, alitame, aspartame, D-glucose, dulcin, monellin, neohesperidin dihydrochalcone (NHDHC), saccharin, sodium superaspartame, stevioside, sucralose (TGS), sucrose, suosan, thaumatin and xylitol, as well as the non-sweet stimuli NaC1, citric acid, tannin and quinine hydrochloride. In M.murinus the effects of the taste modifiers gymnemic acid and miraculin on the CT response were recorded. Conditioned taste aversion (CTA) experiments in M.murinus and two-bottle preference (TBP) tests in E.mongoz were also conducted. We found that all of the above tastants except thaumatin elicited a CT response in both species. The CTA technique showed that M.murinus generalized from sucrose to monellin but not to thaumatin. The intake of aspartame, ranging in concentration from 0.1 to 30 mM was measured in E.mongoz with TBP tests. At no concentration did we see a preference, but there was a significant rejection of 10 and 30 mM aspartame (P←0.025). Miraculin had no effects on the CT response to acids, and gymnemic acid did not selectively suppress the CT response to sucrose or that of any other sweeteners. The absence of ability to taste thaumatin in these species supports the dichotomy between catarrhine and non-catarrhine species. The difference in results with thaumatin and monellin indicate that their sweet moieties are not identical. It also points to a phylogenetic difference in taste within the prosimian group. Further, the results with aspartame indicate that the perception of sweetness from aspartame is limited to catarrhine species. Finally, neither miraculin nor gymnemic acid exhibit the same taste modifying effects in lemuriformes as they do in hominoidea. Thus the results with gymnemic acid and miraculin corroborate those obtained earlier in other prosimian

Project Status Report: Ecology and Environment Project

We present here the extended outline and copies of the illustrations used in the Status Report of the IIASA Ecology and Environment Project, presented at Schloss Laxenburg on 21 June 1974. Section 1., "General Review", is covered in the outline. Section 2., "A Case Study of Ecosystem Management", is the subject of a major monograph now in preparation. Section 3., on Selected Conceptual Developments, is in part documented in IIASA Research Reports RR-73-3 and RR-74-3

Nanoparticle Dispersion, Microstructure and Thermal Effect of Multi-doped ZrO2/SiC from Sulphate Induced Electrolyte

Effort to improve the hardness and thermal resilient properties of coating for advanced engineering applications has necessitated this study. Zn sulphate electrolyte was induced with ZrO2-SiC composite particulate at varied current density of 1.5 and 2.0 A/cm2 for 10 minutes. The incorporated composite particles of ZrO2/SiC were varied in other to examine their mechanical responses on zinc electrolyte. The coated films were characterised with scanning electron microscope with attached electron dispersion spectroscopy (SEM/EDS) and atomic force microscopy (AFM). The micro-hardness properties of the coated and thermal aged alloy were determined with high diamond micro-hardness tester. The anti-corrosion progression was examined using linear polarization technique in 3.65% NaCl. From the results, the incorporation of the composite matrix was found to impact significantly on the surface and microhardness properties. The co-deposition of composite submicron on the zinc electrolyte revealed that homogenous grain structure was obtained.To this end, a boost in the performance characteristics was attained due to effective co-deposition parameters in the electrolyte

Reverse Monte Carlo modeling of amorphous silicon

An implementation of the Reverse Monte Carlo algorithm is presented for the study of amorphous tetrahedral semiconductors. By taking into account a number of constraints that describe the tetrahedral bonding geometry along with the radial distribution function, we construct a model of amorphous silicon using the reverse monte carlo technique. Starting from a completely random configuration, we generate a model of amorphous silicon containing 500 atoms closely reproducing the experimental static structure factor and bond angle distribution and in improved agreement with electronic properties. Comparison is made to existing Reverse Monte Carlo models, and the importance of suitable constraints beside experimental data is stressed.Comment: 6 pages, 4 PostScript figure

The position of graptolites within Lower Palaeozoic planktic ecosystems.

An integrated approach has been used to assess the palaeoecology of graptolites both as a discrete group and also as a part of the biota present within Ordovician and Silurian planktic realms. Study of the functional morphology of graptolites and comparisons with recent ecological analogues demonstrates that graptolites most probably filled a variety of niches as primary consumers, with modes of life related to the colony morphotype. Graptolite coloniality was extremely ordered, lacking any close morphological analogues in Recent faunas. To obtain maximum functional efficiency, graptolites would have needed varying degrees of coordinated automobility. A change in lifestyle related to ontogenetic changes was prevalent within many graptolite groups. Differing lifestyle was reflected by differing reproductive strategies, with synrhabdosomes most likely being a method for rapid asexual reproduction. Direct evidence in the form of graptolithophage 'coprolitic' bodies, as well as indirect evidence in the form of probable defensive adaptations, indicate that graptolites comprised a food item for a variety of predators. Graptolites were also hosts to a variety of parasitic organisms and provided an important nutrient source for scavenging organisms

Carotid Intima-Media Thickness Progression as Surrogate Marker for Cardiovascular Risk Meta-Analysis of 119 Clinical Trials Involving 100 667 Patients

Background: To quantify the association between effects of interventions on carotid intima-media thickness (cIMT) progression and their effects on cardiovascular disease (CVD) risk. Methods: We systematically collated data from randomized, controlled trials. cIMT was assessed as the mean value at the common-carotid-artery; if unavailable, the maximum value at the common-carotid-artery or other cIMT measures were used. The primary outcome was a combined CVD end point defined as myocardial infarction, stroke, revascularization procedures, or fatal CVD. We estimated intervention effects on cIMT progression and incident CVD for each trial, before relating the 2 using a Bayesian meta-regression approach. Results: We analyzed data of 119 randomized, controlled trials involving 100 667 patients (mean age 62 years, 42% female). Over an average follow-up of 3.7 years, 12 038 patients developed the combined CVD end point. Across all interventions, each 10 μm/y reduction of cIMT progression resulted in a relative risk for CVD of 0.91 (95% Credible Interval, 0.87–0.94), with an additional relative risk for CVD of 0.92 (0.87–0.97) being achieved independent of cIMT progression. Taken together, we estimated that interventions reducing cIMT progression by 10, 20, 30, or 40 μm/y would yield relative risks of 0.84 (0.75–0.93), 0.76 (0.67–0.85), 0.69 (0.59–0.79), or 0.63 (0.52–0.74), respectively. Results were similar when grouping trials by type of intervention, time of conduct, time to ultrasound follow-up, availability of individual-participant data, primary versus secondary prevention trials, type of cIMT measurement, and proportion of female patients. Conclusions: The extent of intervention effects on cIMT progression predicted the degree of CVD risk reduction. This provides a missing link supporting the usefulness of cIMT progression as a surrogate marker for CVD risk in clinical trials

Mucosal Expression of Type 2 and Type 17 Immune Response Genes Distinguishes Ulcerative Colitis From Colon-Only Crohn's Disease in Treatment-Naive Pediatric Patients

Background & Aims There is controversy regarding the role of the type 2 immune response in the pathogenesis of ulcerative colitis (UC)?few data are available from treatment-naive patients. We investigated whether genes associated with a type 2 immune response in the intestinal mucosa are up-regulated in treatment-naive pediatric patients with UC compared with patients with Crohn's disease (CD)-associated colitis or without inflammatory bowel disease (IBD), and whether expression levels are associated with clinical outcomes. Methods We used a real-time reverse-transcription quantitative polymerase chain reaction array to analyze messenger RNA (mRNA) expression patterns in rectal mucosal samples from 138 treatment-naive pediatric patients with IBD and macroscopic rectal disease, as well as those from 49 children without IBD (controls), enrolled in a multicenter prospective observational study from 2008 to 2012. Results were validated in real-time reverse-transcription quantitative polymerase chain reaction analyses of rectal RNA from an independent cohort of 34 pediatric patients with IBD and macroscopic rectal disease and 17 controls from Cincinnati Children's Hospital Medical Center. Results We measured significant increases in mRNAs associated with a type 2 immune response (interleukin [IL]5 gene, IL13, and IL13RA2) and a type 17 immune response (IL17A and IL23) in mucosal samples from patients with UC compared with patients with colon-only CD. In a regression model, increased expression of IL5 and IL17A mRNAs distinguished patients with UC from patients with colon-only CD (P =.001; area under the receiver operating characteristic curve, 0.72). We identified a gene expression pattern in rectal tissues of patients with UC, characterized by detection of IL13 mRNA, that predicted clinical response to therapy after 6 months (odds ratio [OR], 6.469; 95% confidence interval [CI], 1.553?26.94), clinical response after 12 months (OR, 6.125; 95% CI, 1.330?28.22), and remission after 12 months (OR, 5.333; 95% CI, 1.132?25.12). Conclusions In an analysis of rectal tissues from treatment-naive pediatric patients with IBD, we observed activation of a type 2 immune response during the early course of UC. We were able to distinguish patients with UC from those with colon-only CD based on increased mucosal expression of genes that mediate type 2 and type 17 immune responses. Increased expression at diagnosis of genes that mediate a type 2 immune response is associated with response to therapy and remission in pediatric patients with UC

Variation in care in the management of children with Crohn's disease: Data from a multicenter inception cohort study

Background: Variation in care is common in medical practice. Reducing variation in care is shown to improve quality and increase favorable outcomes in chronic diseases. We sought to identify factors associated with variation in care in children with newly diagnosed Crohn's disease (CD). Methods: Prospectively collected data from a 28-site multicenter inception CD cohort were analyzed for variations in diagnostic modalities, treatment, and follow-up monitoring practices, along with complicated disease outcomes over 3 years in 1046 children. Generalized linear mixed effects models were used to investigate the intercenter variations in each outcome variable. Results: The mean age at diagnosis was 12 years, and 25.9% were nonwhite. The number of participants ranged from 5 to 112 per site. No variation existed in the initial diagnostic approach. When medication exposure was analyzed, steroid exposure varied from 28.6% to 96.9% (P 0.99). Use of immunomodulators (IMs) varied among centers both within 90 days (P < 0.01) and during 3 years of follow-up (P < 0.01). A significant variation was seen at the geographic level with follow-up small bowel imaging and colonoscopy surveillance after initial therapy. Conclusions: Intercenter variation in care was seen with the initial use of steroids and anti-TNF, but there was no difference in total 3-year exposure to these drugs. Variation in the initiation and long-term use of IMs was significant among sites, but further research with objective measures is needed to explain this variation of care. Small bowel imaging or repeat colonoscopy in CD patients was not uniformly performed across sites. As our data show the widespread existence of variation in care and disease monitoring at geographic levels among pediatric CD patients, future implementation of various practice strategies may help reduce the variation in care